SCHEMBL30497263

SCHEMBL30497263

O=C(O)c1nc2ccccc2n1CC1CCCO1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.55
IRAK4 Q9NWZ3 1/20 0.52
ALDH1A1 P00352 5/20 0.51
RECQL P46063 2/20 0.51
LMNA P02545 1/20 0.51
RAB9A P51151 1/20 0.51
KDM4E B2RXH2 7/20 0.50
GLA P06280 3/20 0.50
MAPT P10636 2/20 0.50
PTGER4 P35408 1/20 0.50
HPGD P15428 5/20 0.48
HSD17B10 Q99714 7/20 0.48
TSHR P16473 5/20 0.48
MAPK1 P28482 3/20 0.48
HTT P42858 1/20 0.48
ATM Q13315 1/20 0.48
USP2 O75604 2/20 0.47
GAA P10253 5/20 0.47
CASP1 P29466 5/20 0.47
CASP7 P55210 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30899106 0.94 PTGER4 (0.48) KCNH2IRAK4ALDH1A1RECQLLMNA
SCHEMBL29924458 0.94 PTGER4 (0.48) KCNH2IRAK4ALDH1A1RECQLLMNA
SCHEMBL22029484 0.81 BRD4 (0.51) ALDH1A1RECQLKDM4EPTGER4HSD17B10
SCHEMBL30497309 0.81 BRD4 (0.52) ALDH1A1RECQLKDM4EPTGER4HSD17B10
SCHEMBL30497271 0.79 BRD4 (0.47) ALDH1A1RECQLKDM4EGLAMAPT
SCHEMBL30899119 0.79 KCNH2 (0.46) KCNH2IRAK4ALDH1A1RECQLLMNA
SCHEMBL24142895 0.74 KCNH2 (0.69) KCNH2IRAK4ALDH1A1RECQLLMNA
SCHEMBL10285226 0.74 ALDH1A1 (0.66) KCNH2ALDH1A1LMNAKDM4EGLA
SCHEMBL29056691 0.74 PTGER4 (0.58) KCNH2IRAK4ALDH1A1RECQLLMNA
SCHEMBL13011128 0.73 PTGER4 (0.60) ALDH1A1KDM4EPTGER4HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12497382-B2 GLP-1R modulating compounds GILEAD SCIENCES, INC. (US) 2025-12-16 US disclosed
US-20230391747-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2023-12-07 US disclosed
US-11702404-B2 GLP-1R modulating compounds GILEAD SCIENCES, INC. (US) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702404-B2 GLP-1R modulating compounds GLP1R, GIPR, GPR119 KCNH2 3295/4885IRAK4 995/4885ALDH1A1 3556/4885
US-20230391747-A1 GLP-1R MODULATING COMPOUNDS GLP1R, GIPR, GPR119 KCNH2 3295/4885IRAK4 995/4885ALDH1A1 3556/4885
US-12497382-B2 GLP-1R modulating compounds GLP1R, GIPR, GPR119 KCNH2 3295/4885IRAK4 995/4885ALDH1A1 3556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.